Shares of Allergan Plc soared Tuesday after news broke that the company was being acquired by pharmaceutical giant AbbVie Inc. in a deal worth around $63 billion.
Latest posts by Market Watch (see all)
- ‘I don’t do Facebook’ — the night Jennifer Aniston declined my ‘Friends’ request - September 21, 2019
- Home-builder NVR to join S&P 500 index - September 20, 2019
- Suddenly — four years later — Chipotle’s stock has completed its comeback: CEO tells MarketWatch how his company got the job done - September 20, 2019